A $267 million stock offering last week by Arrowhead Pharmaceuticals, which has its main employment base in Madison, could help the company bring experimental drugs to market and lead to the purchase of other businesses....
Exact Sciences announced Dr. David Ahlquist, co-inventor of Cologuard® has been named a Fellow of the National Academy of Inventors (NAI)....
The state Legislature has passed several bills championed by the Wisconsin Technology Council that would change state laws surrounding startup funding and oversight. ...
Even before current construction is finished, Exact Sciences is planning for another stage of expansion at one of its Madison campuses, which could about double its lab space....
Eighteen state startups took to the stage to pitch their companies during lightning rounds at the Elevator Pitch Olympics in Madison. The annual competition was part of the Wisconsin Early Stage Symposium, a two-day event put on by the Wisconsin Technology Council....
Invenra Inc., a Madison startup that developed a drug discovery platform to identify human multi-specific antibodies for immuno-oncology, is one of the four startups to receive an investment from Wisconsin's Venture Investors....
Here are three reasons why investing in BRT, a high-frequency, high-capacity, limited-stop bus service, must be a critical economic development priority:...
The FDA has approved the test, Cologuard, for eligible, average-risk patients ages 45 and older, which expands the market that Madison, WI-based Exact can address with its product....
The study, which met both primary endpoints, evaluated the efficacy and safety of a single application of StrataGraft in the treatment of deep partial-thickness thermal burns....
FCDI’s new $21 million facility, next to its headquarters at University Research Park, will meet the Food and Drug Administration’s strict standards for Good Manufacturing Practice. With specially filtered air, air-lock entry doors, gowns, gloves and masks worn by workers, and with other provisions, the...